Seminars in Nuclear Medicine

Papers
(The TQCC of Seminars in Nuclear Medicine is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation60
Artificial Intelligence and Machine Learning in Nuclear Medicine: Future Perspectives58
Application of Deep Learning in Breast Cancer Imaging52
Imaging of COVID-19: CT, MRI, and PET47
Imaging of Head and Neck Cancer With CT, MRI, and US46
Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders44
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?44
Ischemic Heart Disease: An Update43
Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions40
PET and SPECT Tracers for Myocardial Perfusion Imaging39
Intelligent Imaging in Nuclear Medicine: the Principles of Artificial Intelligence, Machine Learning and Deep Learning38
Ethical and Legal Challenges of Artificial Intelligence in Nuclear Medicine37
[18F]FDG-PET/CT Radiomics and Artificial Intelligence in Lung Cancer: Technical Aspects and Potential Clinical Applications34
PET/MR in Head and Neck Cancer – An Update31
Clinical Management of COVID-19 Patients – An Update31
Advances in Brain Amyloid Imaging30
Radiomics in PET/CT: Current Status and Future AI-Based Evolutions30
Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors29
Imaging of Tau Pathology in Neurodegenerative Diseases: An Update28
Recent Developments in SPECT/CT27
Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies26
Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images26
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls25
FDG-PET/CT of COVID-19 and Other Lung Infections25
Imaging for Response Assessment in Cancer Clinical Trials24
Application and Translation of Artificial Intelligence to Cardiovascular Imaging in Nuclear Medicine and Noncontrast CT23
Sentinel Lymph Node Methods in Breast Cancer23
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer23
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers22
Lymphoscintigraphy for Sentinel Node Mapping in Head and Neck Cancer22
PET Agents in Dementia: An Overview22
A role of FDG-PET/CT for response evaluation in metastatic breast cancer?21
15O-Water PET MPI: Current Status and Future Perspectives20
Clinical Use of PET/MR in Oncology: An Update20
FAPI-avid nonmalignant PET/CT findings: An expedited systematic review19
The Future of Cardiac Molecular Imaging19
How to Design AI-Driven Clinical Trials in Nuclear Medicine19
16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer19
Social Asymmetry, Artificial Intelligence and the Medical Imaging Landscape18
PET/CT Variants and Pitfalls in Gynecological Cancers17
Radiation Dosimetry in 177Lu-PSMA-617 Therapy17
Hyperpolarized MRI – An Update and Future Perspectives17
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget17
Imaging for Target Delineation in Head and Neck Cancer Radiotherapy16
Total-body PET/CT – First Clinical Experiences and Future Perspectives16
Radiation Safety and Accidental Radiation Exposures in Nuclear Medicine16
Artificial Intelligence for the Characterization of Pulmonary Nodules, Lung Tumors and Mediastinal Nodes on PET/CT16
PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls16
PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer16
The Role of 18-F FDG PET/CT in Imaging of Endocarditis and Cardiac Device Infections16
PET/CT in Bladder Cancer: An Update16
PET/CT in Non-Hodgkin Lymphoma: An Update15
PET Perfusion and Flow Assessment: Tomorrows’ Technology Today15
PET/CT in Surgical Planning for Head and Neck Cancer14
Digital PET vs Analog PET: Clinical Implications?14
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma14
Measurement of Glomerular Filtration Rate14
Hybrid Imaging of Vascular Cognitive Impairment13
Artificial Intelligence for Response Evaluation With PET/CT13
A Role for FDG PET Radiomics in Personalized Medicine?13
Radiation Dose Modulation of Computed Tomography Component in Positron Emission Tomography/Computed Tomography13
The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer12
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy12
Cardiac PET/MRI: Current Clinical Status and Future Perspectives12
Diagnosis and Image-guided Therapy of Cardiac Left Ventricular Assist Device Infections12
Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma12
Advancement in Production of Radiotracers12
Molecular Imaging of Fever of Unknown Origin: An Update12
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy12
PET/CT Variants and Pitfalls in Breast Cancers12
Variants and Pitfalls of PET/CT in Neuroendocrine Tumors11
Multimodality Imaging and Artificial Intelligence for Tumor Characterization: Current Status and Future Perspective11
SPECT and PET Radiotracers in Renal Imaging11
The Impact of Radiopharmaceutical Therapy on Renal Function11
Advances in PET/CT Technology: An Update11
Mediastinal Masses: 18F-FDG-PET/CT Features Based on the International Thymic Malignancy Interest Group Classification11
Cardiac Imaging With 123I-meta-iodobenzylguanidine and Analogous PET Tracers: Current Status and Future Perspectives11
Role of Non-FDG-PET/CT in Head and Neck Cancer11
PET/MR Technology: Advancement and Challenges11
A Clinical Role of PET in Atherosclerosis and Vulnerable Plaques?11
A Role of PET/MR in Breast Cancer?11
PET/CT in Hodgkin Lymphoma: An Update11
Pitfalls on PET/MRI11
0.019901037216187